Eric Carlson: Lawyer with Edwards Wildman Palmer LLP

Eric Carlson

Associate
Boston,  MA  U.S.A.
Phone617-239-0151

Peer Rating
N/R
 N/R

Client Rating

Printer Friendly VersionEmail this PageDownload to My Outlook ContactsAdd lawyer to My FavoritesCompare this lawyer to other lawyers in your favorites

Experience & Credentials
 

Practice Areas

  • Business Law
  • Mergers & Acquisitions
  • Private Equity
  • Technology
  • Venture Capital
  • Healthcare
  • Life Sciences
 
University Babson College, B.S., Business Administration, magna cum laude, Honors Program, 2002
 
Law SchoolSuffolk University Law School, J.D., magna cum laude, 2009
 
Admitted2009, Massachusetts
 
BornBoston, Massachusetts, 1980
 
Biography

Eric is an associate in the Business Law Department. Eric represents private equity firms, investors and private companies in a broad range of strategic transactions. His practice focuses on private equity, venture capital, mergers and acquisitions and general corporate representation.

Notable Transactional Experience
•Advised GnuBio Inc., a developer of fully integrated droplet-based DNA sequencing technology, as general counsel and in its acquisition by Bio-Rad Laboratories, Inc. in a merger transaction including milestone based contingent payments.

•Represented Boston Dynamics, Inc., an advanced robotics development company, in its acquisition by Google, Inc.

•Represented a Canadian telecommunications equipment company (multi wavelength laser, with advanced photonics, characterized by innovative power, size and cost parameters for data centers) in its initial venture capital financing

•Represented Ampersand Capital Partners in the sale of CoreLab Partners, Inc. and take-private of Bioclinica, Inc., both global clinical trial solutions businesses.

•Represented Stemline Therapeutics, Inc. in its initial public offering.

•Represented Modified Polymer Components, Inc. in its acquisition of Biomedical Structures, LLC.

•Represented existing management and a new investor team in a buyout and recapitalization of a leading supplier of liquid and gaseous oxygen and nitrogen generators and water treatment systems for the military, medical, and oil & gas markets.

•Represented Ampersand Capital Partners in multiple investments, including its investments in Roadrunner Pharmacy, a veterinary pharmacy; Modified Polymer Components, a manufacturer of polymer components for medical device OEMs; and ATS Labs, an antimicrobial testing services business.

•Represented two separate venture-funded biotechs in asset-focused reorganizations and strategic spin-off transactions, transitioning from single C corporation structures to LLC structures with several C corporation subsidiaries.

•Represented Magellan Diagnostics in its strategic spin-off of Dynex Technologies, Inc.

•Represented Magellan Diagnostics in the sale of its microbiology testing products division, TREK Diagnostic Systems, to Thermo Fischer Scientific.

•Represented multiple private companies in venture capital financings, including an early-stage technology company, a clinical trial support services company and a drug research and development company.

Notable Corporate Counsel Experience
•Albert Einstein College of Medicine of Yeshiva University

•Ampersand Capital Partners

•Castlewood Surgical, Inc.

•CoreLab Partners, Inc.

•Dynex Technologies, Inc.

•GnuBIO Inc.

•Magellan Biosciences, Inc.

•Modified Polymer Components, Inc.

Before Edwards Wildman

Prior to joining the firm, Eric was the Operations & Client Services Coordinator for a national background screening and security consulting firm. Eric assisted large and small companies, government contractors, and public utilities develop and maintain comprehensive personnel security programs. Eric's responsibilities included regulatory compliance, client service, and IT planning and support. During law school, Eric served on the editorial board of the Suffolk Transnational Law Review.

Besides Edwards Wildman

Eric enjoys spending time with his young family and is a passionate sports fan.

Experience

Intervale Capital's Equity Investment in Transform Fuels LLC

A Boston-based team of Edwards Wildman attorneys represented firm client Intervale Capital in their private equity investment in Transform Fuels LLC.

Edwards Wildman Represents Boston Dynamics in Its Acquisition by Google

Edwards Wildman represented Boston Dynamics, an MIT robotics spinoff which the firm has advised for two decades, in its acquisition by Google, Inc. Boston Dynamics is renowned for designing legged machines that balance and walk on legs.

Ranovus Class A Financing

An Edwards Wildman team represented Ranovus, Inc. in its $11 million Class A financing.

Forma Therapeutics Subsequent Round Financing

Our Business Law lawyers represented Forma Therapeutics, Inc. in an amendment to Series C1 Preferred Stock Financing as Enterprise Shares.

Enanta Closes IPO

In 2013, our Business Law lawyers represented Enanta Pharmaceuticals, in its initial public offering (IPO), which raised $64 million for Enanta's development of new compounds for combination treatment regimens for Hepatitis C.

Acquisition and Combination of CoreLab Partners, Inc. and BioClinica, Inc.

A team of lawyers at Edwards Wildman represented Ampersand Capital Partners and SV Life Sciences in the investment in membership interests used, in part, to fund the acquisition of CoreLab Partners, Inc. and BioClinica, Inc.

CoreLab Partners Cash-Out Merger with BioClinica

Our Business Law lawyers represented CoreLab Partners, Inc. in its sale structured as a strategic cash-out merger to BioClinica.

Advised Modified Polymer Components, Inc. in a Strategic Merger with Biomedical Structures, LLC

A team of Edwards Wildman lawyers advised Modified Polymer Components, Inc. in a strategic merger with Biomedical Structures, LLC.

Stemline Therapeutics, Inc IPO

In January 2013, Edwards Wildman corporate, finance, insurance and intellectual property team members from Boston and Chicago advised Stemline Therapeutics, Inc. on its Initial Public Offering.

ATS Labs Acquisition of Microcheck

In December 2012 our lawyers represented ATS, Labs, Inc. in the asset purchase of Microcheck.

News
Edwards Wildman Represents Local Robotics Firm in Its Acquisition by Google, Reports Massachusetts Lawyers Weekly
December 19, 2013
Edwards Wildman Advises Boston Dynamics in Its Acquisition by Google, Reports Am Law Daily
December 18, 2013
Edwards Wildman Represents Boston Dynamics in Its Acquisition by Google
December 17, 2013
Edwards Wildman Closes Stemline Therapeutics IPO in First Biotech IPO of 2013
February 5, 2013
Edwards Wildman Advises CoreLabs and Ampersand Capital Partners in Two-Step Acquisition, Reports The Deal
January 31, 2013

 
ISLN920935512
 
Profile Visibility
#1,508 in weekly profile views out of 19,871 lawyers in Boston, Massachusetts
#111,830 in weekly profile views out of 1,616,736 total lawyers Overall

Office Information

Eric Carlson

111 Huntington Avenue
BostonMA 02199-7613




Loading...
 

Professional Networking for Legal Professionals Only

Quickly and easily expand your professional
network - join the premier global network for legal professionals only. It's powered by the
Martindale-Hubbell database - over 1,000,000 lawyers strong.
Join Now